S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
NASDAQ:CSII

Cardiovascular Systems Stock Forecast, Price & News

$23.26
-0.46 (-1.94%)
(As of 11/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$21.75
$23.56
50-Day Range
$22.94
$36.77
52-Week Range
$21.75
$48.28
Volume
422,321 shs
Average Volume
224,533 shs
Market Capitalization
$943.22 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.88
30 days | 90 days | 365 days | Advanced Chart
Receive CSII News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardiovascular Systems and its competitors with MarketBeat's FREE daily newsletter.


Cardiovascular Systems logo

About Cardiovascular Systems

Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St. Paul, MN.

Headlines

Cardiovascular Systems (NASDAQ:CSII) Shares Gap Down to $26.00
November 17, 2021 |  americanbankingnews.com
Cardiovascular Systems (NASDAQ:CSII) Sets New 52-Week Low at $26.36
November 15, 2021 |  americanbankingnews.com
Cardiovascular Systems (NASDAQ:CSII) Sees Large Volume Increase
November 10, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:CSII
CUSIP
14161910
Employees
779
Year Founded
1989

Sales & Book Value

Annual Sales
$258.97 million
Book Value
$6.49 per share

Profitability

Net Income
$-13.42 million
Pretax Margin
-7.65%

Debt

Price-To-Earnings

Miscellaneous

Free Float
39,334,000
Market Cap
$943.22 million
Optionable
Optionable

Company Calendar

Last Earnings
11/08/2021
Today
11/27/2021
Next Earnings (Estimated)
2/02/2022
Fiscal Year End
6/30/2022

Social Links


MarketRank

Overall MarketRank

2.02 out of 5 stars

Medical Sector

584th out of 1,391 stocks

Surgical & Medical Instruments Industry

58th out of 125 stocks

Analyst Opinion: 3.3Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -












Cardiovascular Systems (NASDAQ:CSII) Frequently Asked Questions

Is Cardiovascular Systems a buy right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardiovascular Systems in the last twelve months. There are currently 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Cardiovascular Systems stock.
View analyst ratings for Cardiovascular Systems
or view top-rated stocks.

How has Cardiovascular Systems' stock price been impacted by Coronavirus?

Cardiovascular Systems' stock was trading at $36.32 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CSII stock has decreased by 36.0% and is now trading at $23.26.
View which stocks have been most impacted by COVID-19
.

When is Cardiovascular Systems' next earnings date?

Cardiovascular Systems is scheduled to release its next quarterly earnings announcement on Wednesday, February 2nd 2022.
View our earnings forecast for Cardiovascular Systems
.

How were Cardiovascular Systems' earnings last quarter?

Cardiovascular Systems, Inc. (NASDAQ:CSII) announced its quarterly earnings data on Monday, November, 8th. The medical device company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by $0.12. The medical device company earned $58.40 million during the quarter, compared to analysts' expectations of $63.72 million. Cardiovascular Systems had a negative trailing twelve-month return on equity of 7.40% and a negative net margin of 7.77%. The business's quarterly revenue was down 3.5% compared to the same quarter last year. During the same period last year, the company earned ($0.05) earnings per share.
View Cardiovascular Systems' earnings history
.

What guidance has Cardiovascular Systems issued on next quarter's earnings?

Cardiovascular Systems updated its FY 2022 earnings guidance on Tuesday, November, 23rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $265 million-$285 million, compared to the consensus revenue estimate of $295.53 million.

What price target have analysts set for CSII?

7 analysts have issued twelve-month price objectives for Cardiovascular Systems' shares. Their forecasts range from $40.00 to $49.00. On average, they expect Cardiovascular Systems' stock price to reach $43.40 in the next twelve months. This suggests a possible upside of 86.6% from the stock's current price.
View analysts' price targets for Cardiovascular Systems
or view top-rated stocks among Wall Street analysts.

Who are Cardiovascular Systems' key executives?

Cardiovascular Systems' management team includes the following people:
  • Scott R. Ward, Chairman, President & Chief Executive Officer
  • Rhonda J. Robb, Chief Operating Officer
  • Jeffrey S. Points, Chief Financial Officer
  • Ryan D. Egeland, Chief Medical Officer
  • Sandra M. Sedo, Chief Compliance Officer

What is Scott Ward's approval rating as Cardiovascular Systems' CEO?

12 employees have rated Cardiovascular Systems CEO Scott Ward on Glassdoor.com. Scott Ward has an approval rating of 81% among Cardiovascular Systems' employees.

What other stocks do shareholders of Cardiovascular Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardiovascular Systems investors own include Gilead Sciences (GILD), AbbVie (ABBV), Advanced Micro Devices (AMD), Medtronic (MDT), Pfizer (PFE), (XEL), ACADIA Pharmaceuticals (ACAD), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK) and Procter & Gamble (PG).

What is Cardiovascular Systems' stock symbol?

Cardiovascular Systems trades on the NASDAQ under the ticker symbol "CSII."

Who are Cardiovascular Systems' major shareholders?

Cardiovascular Systems' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (16.50%), Janus Henderson Group PLC (3.76%), Renaissance Technologies LLC (2.57%), New York State Common Retirement Fund (1.89%), Geode Capital Management LLC (1.85%) and Invesco Ltd. (1.62%). Company insiders that own Cardiovascular Systems stock include Alexander Rosenstein, Erik Paulsen, Martha Goldberg Aronson, Rhonda J Robb, Sandra Sedo and Scott R Ward.
View institutional ownership trends for Cardiovascular Systems
.

Which institutional investors are selling Cardiovascular Systems stock?

CSII stock was sold by a variety of institutional investors in the last quarter, including Wellington Management Group LLP, BlackRock Inc., Janus Henderson Group PLC, Macquarie Group Ltd., Eagle Asset Management Inc., Granahan Investment Management Inc. MA, Two Sigma Investments LP, and Perkins Capital Management Inc..
View insider buying and selling activity for Cardiovascular Systems
or view top insider-selling stocks.

Which institutional investors are buying Cardiovascular Systems stock?

CSII stock was purchased by a variety of institutional investors in the last quarter, including Neuberger Berman Group LLC, Invesco Ltd., Assenagon Asset Management S.A., Goldman Sachs Group Inc., AlphaCrest Capital Management LLC, Millennium Management LLC, Summit Global Investments, and Exchange Traded Concepts LLC. Company insiders that have bought Cardiovascular Systems stock in the last two years include Erik Paulsen, Martha Goldberg Aronson, Rhonda J Robb, and Scott R Ward.
View insider buying and selling activity for Cardiovascular Systems
or or view top insider-buying stocks.

How do I buy shares of Cardiovascular Systems?

Shares of CSII can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cardiovascular Systems' stock price today?

One share of CSII stock can currently be purchased for approximately $23.26.

How much money does Cardiovascular Systems make?

Cardiovascular Systems has a market capitalization of $943.22 million and generates $258.97 million in revenue each year. The medical device company earns $-13.42 million in net income (profit) each year or ($0.51) on an earnings per share basis.

How many employees does Cardiovascular Systems have?

Cardiovascular Systems employs 779 workers across the globe.

When was Cardiovascular Systems founded?

Cardiovascular Systems was founded in 1989.

What is Cardiovascular Systems' official website?

The official website for Cardiovascular Systems is www.csi360.com.

Where are Cardiovascular Systems' headquarters?

Cardiovascular Systems is headquartered at 1225 OLD HWY 8 NW, ST. PAUL MN, 55112.

How can I contact Cardiovascular Systems?

Cardiovascular Systems' mailing address is 1225 OLD HWY 8 NW, ST. PAUL MN, 55112. The medical device company can be reached via phone at (651) 259-1600, via email at [email protected], or via fax at 612-677-3355.


This page was last updated on 11/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.